1,694
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Design, synthesis, and biological properties of triazole derived compounds and their transition metal complexes

&
Pages 737-749 | Received 12 Aug 2009, Accepted 05 Oct 2009, Published online: 22 Jun 2010

Abstract

Triazole derived Schiff bases and their metal complexes (cobalt(II), copper(II), nickel(II), and zinc(II)) have been prepared and characterized using IR, 1H and 13C NMR, mass spectrometry, magnetic susceptibility and conductivity measurements, and CHN analysis data. The structure of L2, N-[(5-methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine, has also been determined by the X-ray diffraction method. All the metal(II) complexes showed octahedral geometry except the copper(II) complexes, which showed distorted octahedral geometry. The triazole ligands and their metal complexes have been screened for their in vitro antibacterial, antifungal, and cytotoxic activity. All the synthesized compounds showed moderate to significant antibacterial activity against one or more bacterial strains. It is revealed that all the synthesized complexes showed better activity than the ligands, due to coordination.

Introduction

Triazoles are widely known to possess broad-spectrum biological activities such as antibacterialCitation1–4, antifungalCitation5–8, anticonvulsantCitation9–11, antitumorCitation12–14, antitubercularCitation15–19, antimicrobialCitation20–24, anticancerCitation25–27, analgesicCitation28, cytotoxicCitation29, insecticidal, herbicidal, plant growth regulatoryCitation30–32, and antiproliferative activitiesCitation33,Citation34. These are extensively used as prospective ligands in a variety of bioinorganic syntheses. Due to their significant biological applications they have gained much attention in bioinorganic and metal-based drug chemistry. In view of its structural and biological importance, we have synthesized a series of triazole derived Schiff bases, N-(thiophen-2-ylmethylidene)-1H-1,2,4-triazol-3-amine (L1), N-[(5-methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L2), N-[(3-methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L3), N-[(5-chlorothiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L4), and N-[(5-nitrothiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L5), from the reaction of 3-amino-1,2,4-triazole and methyl-, chloro-, and nitro-substituted thiophene-2-carboxaldehydes. It coordinates to metal ions such as Cu(II), Co(II), Ni(II), and Zn(II) in different ways depending upon the donor sites of the ligandCitation35–40. These compounds have been investigated for their in vitro antibacterial activity against four Gram-negative (Escherichia coli, Shigella sonnei, Pseudomonas aeruginosa, Salmonella typhi) and two Gram-positive (Staphylococcus aureus, Bacillus subtilis) bacterial strains and for antifungal activity against Trichophyton longifusus, Candida albicans, Aspergillus flavus, Microsporum canis, Fusarium solani, and C. glabrata fungal strains. These studies indicate that all the compounds show moderate to significant activity that increases upon coordination/chelation. These compounds were also checked in the in vitro brine shrimp bioassay.

Materials and methods

All reagents and solvents used were of Analar grade. All metals were used as the chloride salts. Melting points were recorded on a Fisher Johns melting point apparatus. Infrared (IR) spectra were recorded on a Shimadzu FT-IR spectrometer. C, H, and N analysis was carried out using a PerkinElmer model. 1H and 13C nuclear magnetic resonance (NMR) spectra were recorded in dimethylsulfoxide (DMSO)-d6 using tetramethylsilane (TMS) as internal standard on a Bruker Spectrospin Avance DPX-500 spectrometer. Electron impact mass spectra (EIMS) were recorded on a Jeol MS Route instrument. In vitro antibacterial, antifungal, and cytotoxic properties were studied at the HEJ Research Institute of Chemistry, International Center for Chemical Sciences, University of Karachi, Pakistan and the Department of Chemistry, The Islamia University of Bahawalpur, Pakistan.

Synthesis of ligands

N-(Thiophen-2-ylmethylidene)-1H-1,2,4-triazol-3-amine (L1)

A mixture of thiophene-2-carboxaldehyde (1.12 g, 0.93 mL, 10 mmol) and 3-amino-1,2,4-triazole (0.84 g, 10 mmol) in methanol (40 mL) was refluxed for 5 h with monitoring by thin layer chromatography (TLC). The reaction mixture was cooled to room temperature and filtered; within 1 h a fine off-white solid product separated from the clear solution. It was filtered, washed with methanol, dried, and recrystallized from hot ethanol. The same procedure was used for the synthesis of all other ligands.

Physical, analytical, and spectral data of the ligands (L1–L5)

N-(Thiophen-2-ylmethylidene)-1H-1,2,4-triazol-3-amine (L1)

Yield (1.26 g, 71%); m.p. 172°C; IR (KBr, cm−1): 3175 (NH), 1628 (HC=N), 1611 (C=N, triazole), 1570, 1540 (C=C), 1020 (N-N), 960 (C-S); 1H NMR (DMSO-d6): δ 7.24 (dd, 1H, J = 4.6, 4.0 Hz, C4-H), 7.76 (d, 1H, J = 4.0 Hz, C3-H), 7.83 (d, 1H, J = 4.6 Hz, C5-H), 8.25 (s, 1H, C6-H), 9.30 (s, 1H, triazole), 13.98 (s, 1H, triazole, NH); 13C NMR (DMSO-d6): δ 126.7 (C5), 129.5 (C4), 132.6 (C3), 143.6 (C2), 152.7 (C8), 156.2 (C6), 157.9 (C7); EIMS (70 eV) m/z (%): 178 ([M]+, 77), 177 (100), 151 (6), 145 (11), 137 (15), 122 (12), 110 (20), 96 (11), 69 (16); Anal. Calcd. for C7H6N4S (178.21): C, 47.18; H, 3.39; N, 31.44. Found: C, 47.30; H, 3.41; N, 31.35%.

N-[(5-Methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L2)

Yield (1.40g, 73%); m.p. 168°C; IR (KBr, cm−1): 3185 (NH), 965 (C-S), 1632 (HC=N), 1612 (C=N, triazole), 1575, 1545 (C=C), 1020 (N-N); 1H NMR (DMSO-d6): δ 2.5 (s, 3H, C5-CH3), 6.96 (d, 1H, J = 3.0 Hz, C4-H), 7.60 (d, 1H, J = 3.0 Hz, C3-H), 8.20 (s, 1H, C6-H), 9.20 (s, 1H, triazole), 13.95 (s, 1H, triazole, NH); 13C NMR (DMSO-d6): δ 15.4 (CH3), 128.2 (C4), 130.9 (C3), 137.6 (C5), 142.9 (C2), 153.5 (C8), 156.5 (C6), 158.2 (C7); EIMS (70 eV) m/z (%): 192 (M+, 81%), 191 (100), 177 (9), 159 (22), 124 (26), 122 (15), 109 (10), 97 (10), 69 (15); Anal. Calcd. for C8H8N4S (192.24): C, 49.98; H, 4.19; N, 29.14. Found: C, 50.10; H, 4.10; N, 29.20%

N-[(3-Methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L3)

Yield (1.42 g, 74%); m.p. 172°C; IR (KBr, cm−1): 3180 (NH), 970 (C-S), 1626 (HC=N), 1615 (C=N, triazole), 1568, 1540 (C=C), 1020 (N-N); 1H NMR (DMSO-d6): δ 2.40 (s, 3H, C3-CH3), 7.06 (d, 1H, J = 4.5 Hz, C4-H), 7.75 (d, 1H, J = 4.5 Hz, C5-H), 8.20 (s, 1H, C6-H), 9.25 (s, 1H, triazole), 13.90 (s, 1H, triazole, NH); 13C NMR (DMSO-d6): δ 14.4 (CH3), 128.4 (C2), 129.3 (C4), 132.9 (C5), 140.6 (C3), 153.1 (C8), 156.8 (C6), 158.2 (C7); EIMS (70 eV) m/z (%): 192 (M+, 68 %), 191 (40), 177 (100), 150 (13), 134 (15), 124 (31), 123 (40), 109 (21), 97 (22), 80 (11), 70 (14), 65 (13); Anal. Calcd. for C8H8N4S (192.24): C, 49.98; H, 4.19; N, 29.14. Found: C, 49.80; H, 4.00; N, 29.3%.

N-[(5-Chlorothiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L4)

Yield (1.47 g, 69%); m.p. 178°C; IR (KBr, cm−1): 3190 (NH), 970 (C-S), 1627 (HC=N), 1610 (C=N, triazole), 1570, 1540 (C=C), 1020 (N-N), 820 (C-Cl); 1H NMR (DMSO-d6): δ 7.39 (d, 1H, J = 3.5 Hz, C4-H), 7.70 (d, 1H, J = 3.5 Hz, C3-H), 8.5 (s, 1H, C6-H), 9.24 (s, 1H, triazole), 13.99 (s, 1H, triazole, NH); 13C NMR (DMSO-d6): δ 128.9 (C3), 132.5 (C4), 135.6 (C5), 146.2 (C2), 153.3 (C8), 156.9 (C6), 158.6 (C7); EIMS (70 eV) m/z (%): 212 (M+, 34), 211 (60), 196 (44), 177 (46), 162 (27), 161 (100), 155 (13), 149 (13), 134 (17), 112 (15), 76 (17), 69 (15), 51 (11); Anal. Calcd. for C7H5ClN4S (212.66): C, 39.54; H, 2.37; N, 26.35. Found: C, 39.70; H, 2.34; N, 26.26%.

N-[(5-Nitrothiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L5)

Yield (1.74 g, 79%); m.p. 203°C; IR (KBr, cm−1): 3175 (NH), 980 (C-S), 1624 (HC=N), 1612 (C=N, triazole), 1560, 1540 (C=C), 1370 (NO2), 1020 (N-N); 1H NMR (DMSO-d6): δ 7.72 (d, 1H, J = 4.1 Hz, C3-H), 7.87 (d, 1H, J = 4.1 Hz, C4-H), 8.30 (s, 1H, C6-H), 9.27 (s, 1H, triazole), 14.00 (s, 1H, triazole, NH); 13C NMR (DMSO-d6): δ 129.9 (C3), 133.8 (C4), 141.2 (C5), 147.0 (C2), 153.6 (C8), 157.7 (C6), 159.1 (C7); EIMS (70 eV) m/z (%): 223 (M+, 75), 182 (10), 177 (100), 150 (30), 136 (17), 123 (15), 109 (27), 95 (33), 82 (10), 69 (23); Anal. Calcd. for C7H5N5S (223.21): C, 37.67; H, 2.26; N, 31.38. Found: C, 37.78; H, 2.34; N, 31.26%.

X-ray structure of N-[(5-methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L2)

The X-ray structure of one of the ligands, N-[(5-methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine (L2), was determined and publishedCitation41 by us elsewhere, and is presented here as and for authentication.

Figure 1. ORTEP diagram of a single molecule in asymmetric unit of L2.

Figure 1.  ORTEP diagram of a single molecule in asymmetric unit of L2.

Figure 2. The unit cell packing in L2.

Figure 2.  The unit cell packing in L2.

General procedure for the preparation of metal(II) complexes (1–20)

Cobalt(II) complex with N-(thiophen-2-ylmethylidene)-1H-1,2,4-triazol-3-amine (L1)

A warm ethanol (20 mL) solution of Co(II)Cl2.6H2O (0.238 g, 1 mmol) was added drop-wise to a magnetically stirred solution of N-(thiophen-2-ylmethylidene)-1H-1,2,4-triazol-3-amine (L1) (0.356 g, 2 mmol) in ethanol (25 mL). The mixture was refluxed for 2 h and cooled to room temperature. On cooling, a colored precipitate product was formed which was filtered, washed with ethanol and then ether, and dried. Crystallization from aqueous ethanol (30:70) gave the desired metal complex. Physical, analytical, and spectral data of Co(II), Ni(II), Cu(II), and Zn(II) complexes are given in and . The same method was used for the preparation of all other complexes.

Table 1. Physical measurements and analytical data of the metal(II) complexes.

Table 2. Conductivity, magnetic, and spectral data of metal(II) complexes.

NMR data of Zn(II) complexes

[Zn(L1)2Cl2] (4)

1H NMR of Zn(II) complex (DMSO-d6): δ 7.30 (dd, 2H, J = 4.6, 4.0 Hz, C4-H), 7.80 (d, 2H, J = 4.0 Hz, C3-H), 7.95 (d, 2H, J = 4.6 Hz, C5-H), 8.50 (s, 1H, C6-H), 9.46 (s, 2H, triazole), 14.0 (s, 2H, triazole, NH); 13C NMR (DMSO-d6): δ 127.5 (C5), 129.8 (C4), 132.8 (C3), 144.5(C2), 153.9 (C8), 158.3, (C6), 159.4 (C7).

[Zn(L2)2Cl2] (8)

1H NMR of Zn(II) complex (DMSO-d6): δ 2.6 (s, 6H, C5-CH3), 7.0 (d, 2H, J = 3.0 Hz, C4-H), 7.69 (d, 2H, J = 3.0 Hz, C3-H), 8.43 (s, 2H, C6-H), 9.38 (s, 2H, triazole), 14.05 (s, 2H, triazole, NH); 13C NMR (DMSO-d6): δ 15.6 (CH3), 128.4 (C4), 131.1 (C3), 139.1 (C5), 143.6 (C2), 154.9 (C8), 158.7 (C6), 159.7 (C7).

[Zn(L3)2Cl2] (12)

1H NMR of Zn(II) complex (DMSO-d6): δ 2.5 (s, 6H, C3-CH3), 7.12 (d, 2H, J = 4.5 Hz, C4-H), 7.95 (d, 2H, J = 4.5 Hz, C5-H), 8.40 (s, 2H, C6-H), 9.45 (s, 2H, triazole), 14.00 (s, 2H, triazole, NH); 13C NMR (DMSO-d6): δ 14.5 (CH3), 129.0 (C2), 129.4 (C4), 134.6 (C5), 140.7 (C3), 154.2 (C8), 158.7 (C6), 159.3 (C7).

[Zn(L4)2Cl2] (16)

1H NMR of Zn(II) complex (DMSO-d6): δ 7.44 (d, 2H, J = 3.5 Hz, C4-H), 7.75 (d, 2H, J = 3.5 Hz, C3-H), 8.7 (s, 2H, C6-H), 9.40 (s, 2H, triazole), 14.05 (s, 2H, triazole, NH); 13C NMR (DMSO-d6): δ 129.0 (C3), 132.6 (C4), 136.7 (C5), 147.0 (C2), 154.7 (C8), 159.2 (C6), 160.0 (C7).

[Zn(L5)2Cl2] (20)

1H NMR of Zn(II) complex (DMSO-d6): δ 7.79 (d, 2H, J = 4.1 Hz, C3-H), 7.95 (d, 2H, J = 4.1 Hz, C4-H), 8.59 (s, 2H, C6-H), 9.45 (s, 2H, triazole), 14.07 (s, 2H, triazole, NH); 13C NMR (DMSO-d6): δ 130.0 (C3), 133.9 (C4), 142.7 (C5), 147.8 (C2), 154.4 (C8), 159.9(C6) 160.6 (C7).

Biological activity

Antibacterial studies

All the newly synthesized compounds (L1–L5) and their respective metal(II) chelates (1–20) were tested against four Gram-negative (E. coli, S. sonnei, P. aeruginosa, S. typhi) and two Gram-positive (S. aureus, B. subtilis) bacterial strains by the disk diffusion methodCitation42. The test compounds (ligand/complex) were dissolved in DMSO to obtain 10 mg/mL solutions. A known volume (10 µL) of solution was applied with the help of a micropipette onto sterilized filter paper disks. The disks were dried at room temperature overnight and stored in sterile dry containers. Disks soaked with 10 µL of DMSO and dried in air at room temperature were used as the negative control. The standard antibiotic disks used as the positive control were either purchased from the manufacturer or prepared as above in the laboratory by applying a known concentration of standard antibiotic solution. Bacterial cultures were grown in nutrient broth medium at 37°C overnight and spread onto solidified nutrient agar medium in Petri plates using sterilized cotton swabs in a standard microbiological working environmentCitation42. Test and control disks were then applied to the solidified medium surface with the help of sterilized forceps. The plates were incubated at 37°C for 12–15 h. The results were recorded by measuring the zone of inhibition in mm against each compoundCitation42. Ampicillin was used as the reference compound. Experiments were carried out in triplicate and the values obtained were statistically analyzed.

Antifungal activity (in vitro)

Antifungal activities of all compounds were studiedCitation43 against six fungal strains (T. longifusus, C. albicans, A. flavus, M. canis, F. solani, and C. glabrata). Sabouraud dextrose agar (Oxoid, Hampshire, England) was seeded with 105 cfu/mL fungal spore suspensions and transferred to Petri plates. Disks soaked in 20 mL (200 µg/mL in DMSO) of the compounds were placed at different positions on the agar surfaceCitation44. The plates were incubated at 32°C for 7 days. The results were recorded as percentage of inhibition and compared with standard drugs miconazole and amphotericin B.

Minimum inhibitory concentration

Compounds containing significant antibacterial activity (over 80%) were selected for minimum inhibitory concentration (MIC) studies. The minimum inhibitory concentration was determined using the disk diffusion technique by preparing disks containing 10, 25, 50, and 100 µg/mL of the compounds and applying the protocolCitation44.

In vitro cytotoxicity

Brine shrimp (Artemia salina Leach) eggs were hatched in a shallow rectangular plastic dish (22 × 32 cm), filled with artificial seawater, which was prepared with a commercial salt mixture and double distilled waterCitation45. An unequal partition was made in the plastic dish with the help of a perforated device. Approximately 50 mg of eggs were sprinkled into the large compartment, which was darkened, while the smaller compartment was opened to ordinary light. After 2 days, nauplii were collected by a pipette from the light side. A sample of test compound was prepared by dissolving 20 mg of each compound in 2 mL of DMSO. From this stock solution, 500, 50, and 5 µg/mL were transferred to nine vials (three for each dilution were used for each test sample and LD50 is the mean of three values) and one vial was kept as control, having 2 mL of DMSO only. The solvent was allowed to evaporate overnight. After 2 days, when the shrimp larvae were ready, 1 mL of sea-water and 10 shrimps were added to each vial (30 shrimps/dilution) and the volume was adjusted with sea-water to 5 mL per vial. After 24 h the number of survivors was counted. Data were analyzed using Finney’s computer program to determine the LD50 valuesCitation46.

Results and discussion

Chemistry

The Schiff base derivatives of triazole (L1L5) were prepared by refluxing an appropriate amount of 3-amino-1,2,4-triazole with a series of methyl-, chloro-, and nitro-substituted thiophene-2-carboxaldehydes, as shown in . All triazole derivatives were only soluble in methanol, ethanol, dioxane, dimethylformamide, and dimethylsulfoxide. The compositions were consistent with their microanalytical and mass spectral data. The metal(II) complexes (1–20) were prepared in a stoichiometric (metal:ligand, 1: 2) molar ratio. Cobalt, copper, nickel, and zinc were used as the chlorides. Physical measurements and analytical data of complexes 1–20 are given in and .

Scheme 1. Preparation of ligands.

Scheme 1.  Preparation of ligands.

Conductance and magnetic susceptibility measurements

The electrolytic nature of the metal complexes (1–20) was indicated by molar conductance values (in dimethylformamide, DMF) (), which fell in the range 78.6–89.5 Ω−1 cm2 mol−1, showing an electrolytic natureCitation47. The magnetic moment values of the solid metal complexes obtained at room temperature are also given in . The magnetic moment values for Co(II) and Ni(II) complexes were found to be in the ranges of 4.32–4.55 B.M. and 3.28–3.50 B.M., respectively, indicative of three and two unpaired electrons for Co(II) and Ni(II) ions in an octahedral environmentCitation48. The magnetic moment values 1.43–1.64 B.M. for Cu(II) complexes are indicative of one unpaired electron per Cu(II) ion, which suggests that the structures of copper(II) complexes had spin-free distorted octahedral geometryCitation49. All the Zn(II) complexes were found to be diamagnetic.

IR spectra

The characteristic bands of IR spectra of the ligands (L1–L5) and their metal complexes are given in “Materials and methods” above and in . The presence of a strong new band in the ligands at 1624–1632 cm−1 gave a clue of condensation of the carbonyl v(C=O) group of thiophene-2-carboxaldehyde with the amino (NH2) group of triazole to develop an azomethine (HC=N) linkageCitation50, which is also supported by the absence of spectral bands at 1715 and 3325 cm−1 originally assigned to carbonyl v(C=O) and amine v(NH2) stretching vibrations. The IR spectral bands of the ligands at 1610–1615 cm−1 and 1540–1575 cm−1 were assigned to triazole (C=N) and thiophene (C=C), respectively. The IR bands of the ligands at 1624–1632 and 1610–1615 cm−1 assigned to the azomethine (HC=N) vibration and triazole (C=N), respectively, were shifted to lower frequencies at 1603–1616 and 1596–1604 cm−1, by 15–20 cm−1 Citation51, indicating the coordination of azomethine (HC=N) and (C=N) of triazole with the metal(II) ions. In addition to this, new weak bands appeared in all complexes at lower frequency regions 360–370 cm−1 and 520–532 cm−1, which indicated the coordination of metal–sulfur (M-S) and metal–nitrogen (M-N), respectively. The IR spectra of the ligands (L1–L5) and their metal(II) complexes confirmed coordination of the ligands with the metal(II) ions tridentately through the sulfur of thienyl and nitrogens of azomethine (HC=N) and triazole (C=N)Citation52.

1H NMR spectra

1H NMR spectral data of the free ligands (L1–L5) and their Zn(II) complexes are recorded in “Materials and methods.” The exhibited signals of all protons of the Schiff bases due to heteroaromatic/aromatic groups were found to be in their expected regionsCitation53. 1H NMR spectra of the Schiff bases displayed protons due to azomethine (C6-H) and triazole (C8-H) at δ 8.20–8.50 and δ 9.20–9.30 respectively, as singlets. The 1H NMR spectrum of L1 exhibited thienyl C3-H and C5-H as a doublet at 7.76 ppm and 7.83 ppm, respectively. However, the thienyl C4-H of L1 appeared as a double doublet at 7.24 ppm. The peaks appearing at 6.96 ppm and 7.60 ppm were assigned to the protons C4-H and C3-H, respectively, of the thienyl ring as a doublet of L2 Citation54. The spectrum of L3 showed thienyl C4-H and C5-H as a doublet at 7.06 ppm and 7.75 ppm, respectively. 1H NMR spectra of ligands L2 and L3 exhibited methyl protons C3-CH3 and C5-CH3 as singlets at δ 2.4–2.5. In the case of compounds L2 and L3, as C4-H was shielded from the electron-donating effect of methyl (CH3) at the 3- and 5-positions, these appeared upfield at 6.96 ppm and 7.06 ppm as compared to L1 at 7.24 ppm. The 1H NMR spectrum of L4 displayed C3-H and C4-H as a doublet at 7.70 ppm and 7.39 ppm, respectively. The thienyl proton of C3-H and C4-H appeared as a doublet at 7.72 ppm and 7.87 ppm of compound L5, respectively. Due to the electron-withdrawing effect of the NO2 group in compound L5, thienyl C4-H appeared downfield at 7.87 ppm as compared to the thienyl C4-H at 7.24 ppm in ligand L1 Citation55. A broad singlet at δ 13.90–14.0 displayed the NH proton of triazole in all the ligands, which disappeared on exchangement with D2O. By comparing 1H NMR spectra of diamagnetic Zn(II) complexes with the free ligands, the proton signals of the triazole ring (C8-H) and azomethine (CH=N) were assigned a downfield shift by 0.20–0.40 ppm upon coordination. All other protons underwent a downfield shift by 0.11–0.24 ppm due to the increased conjugationCitation56.

13C NMR spectra

13C NMR spectra of the free Schiff bases and their diamagnetic zinc(II) complexes were recorded in DMSO-d6. The 13C NMR spectral data of the free Schiff bases and their zinc(II) complexes along with possible assignments are reported in “Materials and methods.” The carbons were found to be in their expected regionsCitation53. These studies were well supported by the IR and 1H NMR spectral data. The azomethine carbon (C6) of all the Schiff bases appeared in the region of δ 156.2–157.7 ppmCitation55. The 13C NMR spectrum of L1 showed that the thienyl carbons C2, C3, C4, and C5 were found at 143.6, 132.6, 129.5, and 126.7 ppm, respectively. All thienyl carbons in all ligands were present in the region of δ 126.7–147.0. All the ligands showed triazole carbons at δ 152.7–159.1. The methyl groups of ligands L2 and L3 appeared in the region of δ 14.4–15.5. Downfield shifting of the azomethine carbon (C6) from 156.2–157.7 ppm in the triazole Schiff bases to 158.3–159.9 ppm in the metal(II) complexes revealed coordination of the azomethine to the metal atom. Similarly, the carbon atom attached to the N of the triazole ring that participated in the coordination of carbon also showed a downfield shift by 0.24–2.40 ppmCitation54.

Mass spectra

The electron impact mass spectra (EIMS) gave compositions: C7H6N4S, 178.0 (calcd. 178.21); C8H8N4S, 192.0 (192.24); C8H8N4S, 192.2 (192.24); C7H5ClN4S, 212.2 (212.6); and C7H5N5O2S, 223.2 (223.21). L1 showed a base peak at 177 of fragment [C7H5N4S]+; for L2 this was observed at 191 of fragment [C8H7N4S]+; for L3 at 177.2 of fragment [C7H5N4S]+; for L4 at 177.2 of fragment [C7H5N4S]+; and for L5 at 177.2 of fragment [C7H5N4S]+; these are the most expected stable fragments. The most probable fragmentation pattern was the cleavage of C=N (exocyclic as well as endocyclic), C=C, C-C, and C-S bonds.

Electronic spectra

The electronic spectral values of Co(II), Ni(II), Cu(II), and Zn(II) complexes are recorded in . The electronic spectra of Co(II) complexes generally showed three absorption bands in the regions 8502–8675, 17,520–17,710, and 29,910–30,180 cm−1, which may be assigned to 4T1g4T2g(F), 4T1g4A2g(F), and 4T1g4Tg(P) transitions, respectively, and are suggestive of octahedral geometryCitation49,Citation55 around the Co(II) ion. The electronic spectral data of Ni(II) complexes showed d–d bands in the regions 9960–10,130, 15,875–16,210, and 29,272–29,491 cm−1, assignable respectively to the transitions 3A2g(F) → 3T2g(F), 3A2g(F) → 3T1g(F), and 3A2g(F) → 3T2g(F), which are characteristic of Ni(II) in octahedral geometryCitation48,Citation56. The electronic spectra of Cu(II) complexes showed an absorption band in the region 14,670–14,910 cm−1, which may be assigned to the transition 2Eg2T2g. The high-energy band at 25,350–25,540 cm−1 is due to forbidden ligand → metal charge transfer. On the basis of the electronic spectra, a distorted octahedral geometry around the Cu(II) ion is suggestedCitation49,Citation57. The Zn(II) complexes were diamagnetic; they did not show any d–d transition and their spectra were dominatedCitation58 only by the charge transfer band at 28,465–28,728 cm−1.

Biological activity

Antibacterial bioassay (in vitro)

Antibacterial activity of the title Schiff bases and their metal chelates was determined against four Gram-negative (E. coli, S. sonnei, P. aeruginosa, S. typhi) and two Gram-positive (S. aureus, B. subtilis) bacterial strains () according to the literature protocolCitation42. The results for all the synthesized compounds were compared with those of the standard drug ampicillin ( and ). The ligands showed varying degrees of inhibitory effect: low, moderate, and significant, on the growth of the different tested strains, while their metal complexes had only moderate to significant inhibitory effects on the growth of the different tested strains (). The Schiff base ligand L1 possessed significant activity (53–64%) against (c), (d), and (e), moderate activity (45–46%) against (a) and (b), and weaker activity (24%) against (f). The antibacterial activity of compound L2 was found to be significant (56–69%) against (a), (c), and (f), moderate (48–50%) against (b) and (e), and weaker (24%) against (d). Significant activity (64–66%) was observed for ligand L3 against (b) and (d), moderate (44–48%) against (c), (e), and (f), and weaker (30%) against (b). The ligand L4 showed good antibacterial activity (53–66%) against (d), (e), and (f), moderate (46%) activity against (a) and (c), and weaker (33%) against (b). Ligand L5 also showed significant activity (53–66%) against (c), (e), and (f), moderate activity (50%) against (a) and (d), and weaker (25%) against (b). Compounds 1–20 showed overall significant activity (53–85%) against (a), (b), (c), (d), (e), and (f). However, moderate activity (37–50%) was observed for compounds 1, 2, 9, 10, 11, and 12 against (a), 1, 6, 8, 13, 14, 17, and 19 against (b), 9, 10, 11, and 16 against (c), 5 and 8 against (d), 2, 9, and 11 against (e), and 1–6 and 20 against (f). The antibacterial results () evidently show that the activity of the Schiff base compounds was enhanced on coordination with the metal ion. Enhancement in activity of the Schiff bases upon coordination can be explained on the basis of chelation theory. Chelation reduces the polarity of the metal ion to a significant extent due to overlapping with donor groups. Further, the delocalization of π-electrons over the whole chelate ring is increased, which in turn enhances the lipophilicity of the complexesCitation59. The increased lipophilicity in turn enhances the penetration of complexes into lipid membranes, thus killing more bacteria.

Table 3. Antibacterial bioassay (concentration used 1 mg/mL of DMSO) of ligands and metal(II) complexes.

Figure 3. Comparison of antibacterial activity.

Figure 3.  Comparison of antibacterial activity.

Figure 4. Average antibacterial activity.

Figure 4.  Average antibacterial activity.

In vitro antifungal bioassay

The antifungal screening of all compounds was carried out against T. longifusus, C. albicans, A. flavus, M. canis, F. solani, and C. glabrata fungal strains () according to the literature protocolCitation43. Some of the Schiff base derivatives of triazole showed moderate to significant degrees of inhibitory effect on the growth of the tested strains, whereas some showed either low or no inhibitory effect. However, the Schiff base L1 showed significant activity (53–54%) against (c) and (e), L2 showed significant activity (54%) against (f), L3 showed significant activity (57%) against (e), L4 showed significant activity (62%) against (d), and L5 showed significant activity (59–66%) against (d) and (e). The results given in show that compounds 6 and 8 possessed significant activity (53–54%) against (a), 11 and 14 showed significant activity (54–57%) against (b), 1, 3, 4, 6, and 17 had significant activity (54–59%) against (c), 9, 11, and 13–20 possessed significant activity (54–72%) against (d), 1, 2, 4, 8, and 17-20 had significant activity (53–74%) against (e), and 5, 7, 10, 11, 12, and 13 showed significant activity (53–67%) against (f). Most of the other compounds showed moderate and only a few possessed weaker activity against T. longifusus, C. albicans, A. flavus, M. canis, F. solani, and C. glabrata fungal strains. The results of inhibition were compared with the results for the standard drugs, miconazole and amphotericin BCitation44 ( and ).

Table 4. Antifungal bioassay (concentration used 200 µg/mL) of ligands and metal(II) complexes.

Figure 5. Comparison of antifungal activity.

Figure 5.  Comparison of antifungal activity.

Figure 6. Average antifungal activity.

Figure 6.  Average antifungal activity.

Minimum inhibitory concentration (MIC)

The antibacterial results for all the synthesized compounds obtained after preliminary screening showed that compounds 6, 8, 10, 16, and 18 were the most active (above 80%). These five compounds were therefore selected for minimum inhibitory concentration (MIC) studies (). The MIC of these compounds was in the range 35.48–70.66 µg/mL. The MIC results in show that compound 18 was the most active. It inhibited the growth of S. aureus at 35.48 µg/mL.

Table 5. Minimum inhibitory concentration (µg/mL) of selected compounds 6, 8, 10, 16, and 18 against selected bacteria.

In vitro cytotoxic bioassay

The synthesized ligands (L1–L5) and their metal(II) complexes (1–20) were screened for their cytotoxicity (brine shrimp bioassay) using the protocol of Meyer et al.Citation45. The cytotoxic data recorded in reveal that only six compounds, 3, 4, 7, 14, 15, and 20, displayed potent cytotoxic activity, LD50 = 4.47 × 10−5 to 2.52 × 10−4 M, against Artenia salina, while all other compounds can be considered as almost inactive in this assay. It was interesting to note that the metal complexes showed potent cytotoxicity as compared to the ligands. The values of LD50 Citation46 of the synthesized compounds from show that the cytotoxic activity of the copper complexes is better than of the other metal complexes. This activity relationship may help to serve as a basis for future direction toward the development of certain cytotoxic agents for clinical application.

Table 6. Brine shrimp bioassay data of the ligands (L1–L5) and their metal(II) complexes (1–20).

Conclusions

The target compounds were achieved and characterized successfully (). Their screening results revealed that the antibacterial and antifungal activity increases upon chelation/coordination. Chelation reduces the polarity of the metal ion, which in turn increases the lipophilic nature of the metal. This lipophilic character experienced by the metal ions further enhances effective penetration through the lipid layer of the cell membrane of the microorganism by killing the bacteria more efficiently. Further, it has been suggested that some functional groups such as azomethine (HC=N), or heteroatoms present in the compounds, may play an important role in increasing the biological activity of the synthesized compounds.

Figure 7. Proposed structure of the metal complexes.

Figure 7.  Proposed structure of the metal complexes.

Acknowledgements

We also thankful to the HEJ Research Institute of Chemistry, University of Karachi, Pakistan, for providing help in recording NMR and mass spectra and also the antibacterial and antifungal assays.

Declaration of interest

One of the authors (M.H.) is grateful to the Higher Education Commission (HEC), Government of Pakistan, for an award to carry out this research.

References

  • Gulerman NN, Dogan HN, Rollas S, Johansson C, Celik C. Synthesis and structure elucidation of some new thioether derivatives of 1,2,4-triazoline-3-thiones and their antimicrobial activities. Farmaco 2001;56:953–8.
  • Karthikeyan MS, Prasad DJ, Poojary B, Bhat KS, Holla BS, Kumari NS. Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorophenyl moiety. Bioorg Med Chem 2006;14:7482–9.
  • Singh K, Singh DP, Barwa MS, Tyagi P. Some bivalent metal complexes of Schiff bases containing N and S donor atoms. J Enzyme Inhib Med Chem 2006;21:749–55.
  • Bagihalli GB, Avaji PG, Patil SA, Badami PS. Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. Eur J Med Chem 2008;43:2639–49.
  • Rezaei Z, Khabnadideh S, Pakshir K, Hossaini Z, Amiri F, Assadpour E. Design, synthesis and antifungal activity of triazole and benzotriazole derivatives. Eur J Med Chem 2009;44:3064–7.
  • Heubach G, Sachse B, Buerstell H. 1,2,4-Triazole derivatives. Ger Offen 1979;2:826, 760.
  • Singh WM, Dash BC. Synthesis of some new Schiff bases containing thiazole and oxazolenuclei and their fungicidal activity. Pesticides 1988;22:33–7.
  • Reddy V, Patil S, Reddy T, Angadi SD. Synthesis, characterization and biological activities of Cu(II), Co(II), Ni(II), Mn(II) and Fe(III) complexes with Schiff base derived from 3-(4-chlorophenoxymethyl)-4-amino-5-mercapto-1,2,4-triazole. E-J Chem 2008;5:529–38.
  • Chen J, Sun XY, Chai KY, Lee JS, Song MS, Quan ZS. Synthesis and anticonvulsant evaluation of 4-(4-alkoxylphenyl)-3-ethyl-4H-1,2,4-triazoles as open-chain analogues of 7-alkoxyl-4,5-dihydro[1,2,4]triazolo[4,3-a] quinolines. Bioorg Med Chem 2007;15:6775–81
  • Küçükgüzel İ, Küçükgüzel ŞG, Rollas, S, Ötük-Sanış G, Özdemir O, Bayrak İ, et al. 3-(Arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2,4-triazole derivatives and their anticonvulsant activity. Farmaco 2004;59: 893–901.
  • Kelley JL, Koble CS, Davis RG, McLean MS, Soroko FE, Cooper BR. 1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c] pyridines: synthesis and anticonvulsant activity. J Med Chem 1995;38:4131–4.
  • Guo-Qiang H, Li-Li H, Song-Qiang X, Wen-Long H. Design, synthesis and antitumor activity of asymmetric bis(s-triazole Schiff-base) s bearing functionalized side-chain. Chin J Chem 2008;26:1145–9.
  • Bekircan O, Gumrukcuoglu N. Synthesis of some 3,5-diphenyl-4H-1,2,4-triazole derivatives as antitumor agents. Indian J Chem 2005;44B:2107–13.
  • Hanna NB, Dimitrijevich SD, Larson SB, Robsin RK, Revankar GR. Synthesis and single-crystal X-ray diffraction studies of 1-b-D-ribofuranosyl-1,2,4-triazole-3-sulfonamide and certain related nucleosides. J Heterocycl Chem 1988;25:1857–68.
  • Joshi S, Khosla N, Tiwari P. In vitro study of some medicinally important Mannich bases derived from antitubercular agent. Bioorg Med Chem 2004;12:571–6.
  • Kucukguzel I, Kucukguzel SG, Rollas S, Kirazb M. Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials. Biorg Med Chem Lett 2001;11:1703–7.
  • Klimesova V, Zahajska L, Waisser K, Kaustova J, Mollmann U. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives. Farmaco 2004;59:279–88.
  • Dabak K, Sezer O, Akar A, Anac O. Synthesis and investigation of tuberculosis inhibition activities of some 1,2,3-triazole derivatives. Eur J Med Chem 2003;38:215–/18.
  • Monika W, Swatko-Ossor M, Mazur L, Rzaczynska Z, Siwek A. Synthesis, structure and investigations of tuberculosis inhibition activities of new 4-methyl-1-substituted-1H-1,2,4-triazoles-5(4H)-thione. J Heterocycl Chem 2008;45:1893–6.
  • Ulusoy N, Gursoy A, Otuk G. Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Farmaco 2001;56:947–52.
  • Demirbas N, Demirbas A, Alpay Karaoglu S, Elif C. Synthesis and antimicrobial activities of some new [1,2,4]triazolo[3,4-b]thiadiazoles and [1,2,4]triazole[3,4-b][1,3,4]thiadiazines. ARKIVOC 2005;(i):75–91.
  • Demirbas N, Demirbas A, Karaoglu SA. Synthesis and biological activities of new 1,2,4-triazol-3-one derivatives. Russ J Bioorg Chem 2005;31:387–97.
  • Holla BS, Mahalinga M, Karthikeyan MS, Poojary B, Akberali PM. Synthesis, characterization and antimicrobial activity of some substituted 1,2,3-triazoles. Eur J Med Chem 2005;40:1173–8.
  • Salgin-Gökşen U, Gökhan-Kelekçi N, Göktaş O, Köysal Y, Kiliç E, Işik S, et al. 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic, anti-inflammatory and antimicrobial activities. Bioorg Med Chem 2007;15:5738–51.
  • Holla BS, Veerendra B, Shivanada MK, Poojary B. Synthesis, characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. Eur J Med Chem 2003;38:759–67.
  • Danoun S, Baziard-Mouysset G, Stigliani J, Payard M, Selkti M, Viossat B, et al. Addition of diazomethane to 3 and 4-nitrophthalodinitriles. Heterocycl Commun 1998;4:45–51.
  • Bekircan O, Kahveci B, Kucuk M. Synthesis and anticancer evaluation of some new unsymmetrical 3,5-diaryl-4H-1,2,4-triazole derivatives. Turk J Chem 2006;30:29–40.
  • Turan-Zitouni G, Kaplancikli ZA, Erol K, Kilic FS. Synthesis and analgesic activity of some triazoles and triazolothiadiazines. Farmaco 1999;54:218–23.
  • Tarafder MT, Kasbollah A, Saravan N, Crouse KA, Ali AM, Tin OK. S-Methyldithiocarbazate and its Schiff bases: evaluation of bondings and biological properties. J Biochem Mol Biol Biophys 2002;6:85–91.
  • Chu CH, Sun XW, Sun L, Zhang ZY, Li ZC, Liao RA. Synthesis and biological activity of omega-(5-aryl-1,3,4-oxadiazol-2-thio)- and mega-(5-aryl-l,3,4-oxadiazol-2-thioacetoxyl)-omega-(1-H-1,2,4-triazol-1-yl)acetophenones. J Chin Chem Soc 1999;46:229–32.
  • Czollner L, Sxilagli G, Janaky J. Synthesis of new 1,5-diphenyl-3-1H-1,2,4-triazoles substituted with H alkyl, or carboxyl groups at C-3. Arch Pharm 1990;323:225–51.
  • Izumi K, Yamaguchi I, Wada A, Oshio H, Takahashi HN. Effects of a new plant-growth retardant (E)-1-(4-chlorophenyl)-4,4 dimethyl-2-(1,2,4-triazol-1-yl)-1-penten-3-ol (s-3307) on the growth and gibberellin content of rice plants. Plant Cell Physiol 1984;25:611–15.
  • Manfredini S, Vicentini CB, Manfrini M, Bianchi N, Rutigliano C, Mischiati C, et al. Pyrazolo-triazoles as light activable DNA cleaving agents. Bioorg Med Chem 2000;8:2343–2346.
  • Vicini P, Geronikaki A, Incerti M, Busonera B, Poni G, Kabras CA, et al. Synthesis and biological evaluation of benzoisothiazole, benzothiazole and thiazole Schiff bases. Bioorg Med Chem 2003;11:4785–9.
  • Avaji PG, Patil SA, Badami PS. Synthesis, spectral, thermal, solid-state DC electrical conductivity and biological studies of Co(II) complexes with Schiff bases derived from 3-substituted-4-amino-5-hydrazino-1,2,4-triazole and substituted salicylaldehydes. Transition Met Chem 2008;33:275–83.
  • Singh K, Barwa MS, Tyagi P. Synthesis, characterization and biological studies of Co(II), Ni(II), Cu(II) and Zn(II) complexes with bidentate Schiff bases derived by heterocyclic ketone. Eur J Med Chem 2006;41:147–53.
  • Badwaik VB, Aswar AS. Synthesis, characterization and biological studies of some Schiff base complexes. Russ J Coord Chem 2007;33:755–60.
  • Haasnoot JG. Mononuclear, oligonuclear and polynuclear metal coordination compounds with 1,2,4-triazole derivatives as ligands. Coord Chem Rev 2000;200–2:131–85.
  • Chohan ZH, Supuran CT. Structural and biological properties of first row d-transition metal complexes with N-substituted sulfonamides. J Enzyme Inhib Med Chem 2008;23:240–51.
  • Chohan ZH, Shad HA. Structural elucidation and biological significance of 2-hydroxy-1-naphthaldehyde derived sulfonamides and their first row d-transition metal chelates. J Enzyme Inhib Med Chem 2008;23:369–79.
  • Chohan ZH, Hanif M, Tahir MN. N-[(E)-(5-Methylthiophen-2-yl)methylidene]-1H-1,2,4-triazol-3-amine. Acta Crystallogr 2009;E65:0117.
  • Cappuccino JG, Sherman N. Microbiology: A laboratory manual. 4th ed. Addison Wesley Longman, Inc. Harlow, England; 1999. pp: 199–204.
  • Atta-ur-Rahman Choudhary, MI, Thomsen WJ. Bioassay Techniques for Drug Development. Amsterdam: Harwood Academic Publishers, 2001: 22.
  • McLaughlin JL, Chang C-J, Smith DL In. “Bench-top” bioassays for the discovery of bioactive natural products: An update, structure and chemistry (part-B). In:Atta-ur-Rahman, ed. Studies in natural products chemistry, Vol. 9. Amsterdam: Elsevier Science, 1998.
  • Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. Brine shrimp: a convenient general bioassay for active plant constituents. Planta Med 1982;45:31–4.
  • Finney DJ. Probit Analysis, 3rd ed. Cambridge: Cambridge University Press, 1971.
  • Geary WJ. The use of conductivity measurements in organic solvents for the characterisation of coordination compounds. Coord Chem Rev 1971;7:81–122.
  • Balhausen CJ. An Introduction to Ligand Field Theory. New York: McGraw. Hill; 1962.
  • Lever ABP. Inorganic Electronic Spectroscopy. New York: Elsevier, 1984.
  • Yadawe MS, Patil SA. Synthesis, characterization and biological studies of cobalt(II) and nickel(II) complexes with new Schiff bases. Transition Met Chem 1997;22:220–4.
  • Bagihalli GB, Badami PS, Patil SA. Synthesis, spectral characterization and in vitro biological studies of Co(II), Ni(II) and Cu(II) complexes with 1,2,4 triazole Schiff bases. J Enzyme Inhib Med Chem 2009;24:381–94.
  • Chohan ZH, Pervez H, Rauf A, Scozzafava A, Supuran CT. Antibacterial Co(II), Cu(II), Ni(II), and Zn(II) complexes of thiadiazole derived furanyl, thiophenyl and pyrrolyl Schiff bases. J Enzyme Inhib Med Chem 2002;17:117–22.
  • Simmons WW. The Sadtler Handbook of Proton NMR Spectra. Philadelphi, PA: Sadtler Research Laboratories, 1978.
  • Pasto DJ. Organic Structure Determination. London: Prentice Hall International, 1969.
  • Figgis BN. Intoduction to Ligand Fields. New York: John Wiley, 1976.
  • Chohan ZH, Kausar S. Synthesis, structural and biological studies of nickel(II), copper(II) and zinc(II) chelates with tridentate Schiff bases having NNO and NNS donor systems. Chem Pharm Bull (Tokyo) 1993;41:951–3.
  • Drago RS. Physical Methods in Inorganic Chemistry. New York: Reinhold Publishing Corp., 1968.
  • Chohan ZH, Shaikh AU, Supuran CT. In-vitro antibacterial, antifungal and cytotoxic activity of cobalt (II), copper (II), nickel (II) and zinc (II) complexes with furanylmethyl- and thienylmethyl-dithiolenes: 1,3-dithiole-2-one and 1,3-dithiole-2-thione. J Enzyme Inhib Med Chem 2006;21:733–40.
  • Rehman SU, Chohan ZH, Naz F, Supuran CT. In-vitro antibacterial, antifungal and cytotoxic activities of some coumarins and their metal complexes. J Enzyme Inhib Med Chem 2005;20:333–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.